Alzheimer's disease: Diagnosis and treatment

Myron F. Weiner

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This review describes and evaluates developments in the early diagnosis and the treatment of Alzheimer's disease. It is hoped that early diagnosis of the disorder will enable treatment that will reduce or arrest the associated cognitive loss so that affected individuals can retain significant function and institutionalization can be delayed or averted. Diagnostic techniques, including use of neuropsychological measures, functional imaging measures, and biological markers, are reviewed; such techniques are useful for confirming diagnosis but do not replace a comprehensive clinical evaluation. Potential treatment modalities, such as techniques to enhance neurotransmission, replace estrogen effects, reduce the effects of free radicals, and combat inflammation, are explored. Cholinesterase inhibitors are the only modality thus far shown in large-scale studies to be effective, but their effect is small.

Original languageEnglish (US)
Pages (from-to)306-316
Number of pages11
JournalHarvard Review of Psychiatry
Volume4
Issue number6
StatePublished - Mar 1997

Fingerprint

Alzheimer Disease
Early Diagnosis
Institutionalization
Cholinesterase Inhibitors
Synaptic Transmission
Free Radicals
Estrogens
Therapeutics
Biomarkers
Inflammation

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Alzheimer's disease : Diagnosis and treatment. / Weiner, Myron F.

In: Harvard Review of Psychiatry, Vol. 4, No. 6, 03.1997, p. 306-316.

Research output: Contribution to journalArticle

Weiner, MF 1997, 'Alzheimer's disease: Diagnosis and treatment', Harvard Review of Psychiatry, vol. 4, no. 6, pp. 306-316.
Weiner, Myron F. / Alzheimer's disease : Diagnosis and treatment. In: Harvard Review of Psychiatry. 1997 ; Vol. 4, No. 6. pp. 306-316.
@article{aca7da29f3544f96bb90f860c2c1eb0e,
title = "Alzheimer's disease: Diagnosis and treatment",
abstract = "This review describes and evaluates developments in the early diagnosis and the treatment of Alzheimer's disease. It is hoped that early diagnosis of the disorder will enable treatment that will reduce or arrest the associated cognitive loss so that affected individuals can retain significant function and institutionalization can be delayed or averted. Diagnostic techniques, including use of neuropsychological measures, functional imaging measures, and biological markers, are reviewed; such techniques are useful for confirming diagnosis but do not replace a comprehensive clinical evaluation. Potential treatment modalities, such as techniques to enhance neurotransmission, replace estrogen effects, reduce the effects of free radicals, and combat inflammation, are explored. Cholinesterase inhibitors are the only modality thus far shown in large-scale studies to be effective, but their effect is small.",
author = "Weiner, {Myron F.}",
year = "1997",
month = "3",
language = "English (US)",
volume = "4",
pages = "306--316",
journal = "Harvard Review of Psychiatry",
issn = "1067-3229",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Alzheimer's disease

T2 - Diagnosis and treatment

AU - Weiner, Myron F.

PY - 1997/3

Y1 - 1997/3

N2 - This review describes and evaluates developments in the early diagnosis and the treatment of Alzheimer's disease. It is hoped that early diagnosis of the disorder will enable treatment that will reduce or arrest the associated cognitive loss so that affected individuals can retain significant function and institutionalization can be delayed or averted. Diagnostic techniques, including use of neuropsychological measures, functional imaging measures, and biological markers, are reviewed; such techniques are useful for confirming diagnosis but do not replace a comprehensive clinical evaluation. Potential treatment modalities, such as techniques to enhance neurotransmission, replace estrogen effects, reduce the effects of free radicals, and combat inflammation, are explored. Cholinesterase inhibitors are the only modality thus far shown in large-scale studies to be effective, but their effect is small.

AB - This review describes and evaluates developments in the early diagnosis and the treatment of Alzheimer's disease. It is hoped that early diagnosis of the disorder will enable treatment that will reduce or arrest the associated cognitive loss so that affected individuals can retain significant function and institutionalization can be delayed or averted. Diagnostic techniques, including use of neuropsychological measures, functional imaging measures, and biological markers, are reviewed; such techniques are useful for confirming diagnosis but do not replace a comprehensive clinical evaluation. Potential treatment modalities, such as techniques to enhance neurotransmission, replace estrogen effects, reduce the effects of free radicals, and combat inflammation, are explored. Cholinesterase inhibitors are the only modality thus far shown in large-scale studies to be effective, but their effect is small.

UR - http://www.scopus.com/inward/record.url?scp=0030978088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030978088&partnerID=8YFLogxK

M3 - Article

C2 - 9385008

AN - SCOPUS:0030978088

VL - 4

SP - 306

EP - 316

JO - Harvard Review of Psychiatry

JF - Harvard Review of Psychiatry

SN - 1067-3229

IS - 6

ER -